CN107050396A - 一种治疗良性前列腺增生的药物组合物 - Google Patents
一种治疗良性前列腺增生的药物组合物 Download PDFInfo
- Publication number
- CN107050396A CN107050396A CN201710436947.0A CN201710436947A CN107050396A CN 107050396 A CN107050396 A CN 107050396A CN 201710436947 A CN201710436947 A CN 201710436947A CN 107050396 A CN107050396 A CN 107050396A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- benign prostatic
- root
- prostatic hyperplasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 40
- 238000007654 immersion Methods 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 22
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 22
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 22
- 240000002024 Gossypium herbaceum Species 0.000 claims abstract description 22
- 235000004341 Gossypium herbaceum Nutrition 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 22
- 235000003956 Luffa Nutrition 0.000 claims abstract description 22
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 22
- 241000210756 Polyctenium Species 0.000 claims abstract description 22
- 244000197580 Poria cocos Species 0.000 claims abstract description 22
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 22
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 22
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 22
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 22
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 235000005412 red sage Nutrition 0.000 claims abstract description 22
- 239000004575 stone Substances 0.000 claims abstract description 22
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 22
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 21
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 21
- 244000050983 Luffa operculata Species 0.000 claims abstract description 21
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 20
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 20
- 239000002304 perfume Substances 0.000 claims abstract description 19
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 15
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 15
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 238000001704 evaporation Methods 0.000 claims abstract description 11
- 230000008020 evaporation Effects 0.000 claims abstract description 11
- 238000010438 heat treatment Methods 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 244000164480 Curcuma aromatica Species 0.000 claims abstract 5
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 5
- 241001521901 Tribulus lanuginosus Species 0.000 claims abstract 5
- 229940079593 drug Drugs 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 241000825107 Hierochloe Species 0.000 claims description 8
- 235000015466 Hierochloe odorata Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000014258 Polygonum bistorta Nutrition 0.000 claims description 7
- 240000003186 Stachytarpheta cayennensis Species 0.000 claims description 7
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 claims description 7
- 241000173529 Aconitum napellus Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 238000007873 sieving Methods 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 description 18
- 241001533104 Tribulus terrestris Species 0.000 description 17
- 241000218628 Ginkgo Species 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000002386 leaching Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000002309 gasification Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 241000219138 Luffa Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001855 preneoplastic effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000009530 yishen Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草5‑30份、银杏20‑50份、丝瓜络1‑18份、丹参3‑25份、梳篦叶30‑70份、五味子1‑20份、铃子香30‑60份、黄芪3‑25份、莪术3‑30份、棉花根5‑30份、炙甘草2‑30份、王不留行2‑25份、制附子1‑20份、刺蒺藜1‑18份、茯苓2‑25份、石苇1‑12份。取各原料加水浸泡两次，合并两次所得浸液，加热蒸发，浓缩、速冻成粉、过筛即得。本发明制得的药物组合物对良性前列腺增生具有药性平和、标本兼治、疗程短、疗效好、治愈率高、不易复发、无明显不良反应、费用低的特点。本发明制造简单，携带及服用方便，可以快速改善尿流，减轻病人痛苦，提高生活质量，适用于大多数患群。
Description
技术领域
本发明涉及医药技术领域，具体是一种治疗良性前列腺增生的药物组合物。
背景技术
前列腺增生（BPH）是中老年男性常见疾病之一，随全球人口老年化发病日渐增多。前列腺增生的发病率随年龄递增，但有增生病变时不一定有临床症状。城镇发病率高于乡村，而且种族差异也影响增生程度。中医辨证法将其归为“瘾闭”范畴，本病起于膀眯。相关资料显示，膀眯的气化功能直接影响机体尿液的顺利排出，而膀眯的气化功能和肾脏的气化息息相关。由于老年患者肾气虚弱、宗气虚衰，直接影响了患者膀眯的气化功能，使邪气趁机入侵，引发疾病固。因此，临床治疗时，应当以益肾活血为主要治疗原则，同时也要重视将邪气祛除，兼顾标本，方可有效缓解良性前列腺增生的临床症状。常规西药前列康片治疗治疗该病，可以一定程度上缓解患者的临床症状，但是，长期服用该药，会产生较大的副作用，影响预后。
发明内容
本发明的目的在于提供一种治疗良性前列腺增生的药物组合物，以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草5-30份、银杏20-50份、丝瓜络1-18份、丹参3-25份、梳篦叶30-70份、五味子1-20份、铃子香30-60份、黄芪3-25份、莪术3-30份、棉花根5-30份、炙甘草2-30份、王不留行2-25份、制附子1-20份、刺蒺藜1-18份、茯苓2-25份、石苇1-12份。
作为本发明进一步的方案：所述治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草6-28份、银杏25-45份、丝瓜络2-15份、丹参4-22份、梳篦叶35-65份、五味子2-18份、铃子香35-55份、黄芪5-22份、莪术4-28份、棉花根8-25份、炙甘草3-25份、王不留行4-20份、制附子2-18份、刺蒺藜2-15份、茯苓3-22份、石苇1-10份。
作为本发明进一步的方案：所述治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草8-25份、银杏30-42份、丝瓜络4-12份、丹参5-20份、梳篦叶40-60份、五味子3-15份、铃子香38-52份、黄芪8-20份、莪术5-25份、棉花根10-22份、炙甘草3-20份、王不留行6-15份、制附子3-15份、刺蒺藜3-12份、茯苓5-20份、石苇1-8份。
作为本发明进一步的方案：其制备工艺包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量5-10倍重量的水浸泡6-12h后取浸液；在剩余的药渣中加入总药物重量3-6倍重量的水浸泡3-8h后，取浸液；合并两次所得浸液，加热蒸发，浓缩为稠膏；
（2）将稠膏速冻成粉，过100-200目筛即得药物组合物。
作为本发明进一步的方案：步骤（1）中，浓缩为60℃环境下相对密度为1.05-1.20的稠膏。
作为本发明进一步的方案：步骤（1）中，浸泡的温度为30-60℃。
作为本发明进一步的方案：步骤（1）中，加热蒸发的温度为60-70℃。
作为本发明进一步的方案：步骤（2）中，速冻成粉的温度为-5~0℃。
本发明中各原料的作用：
白花蛇草清热解毒；利湿。主肺热喘咳；咽喉肿痛；肠痈；疖肿疮疡；毒蛇咬伤；热淋涩痛；水肿；痢疾；肠炎；湿热黄疸；癌肿。
银杏有降痰、清毒、杀虫之功能，可治疗“疮疥疽瘤、乳痈溃烂、牙齿虫龋、小儿腹泻、赤白带下、慢性淋浊、遗精遗尿等症”。
丝瓜络有祛风，通络，活血，下乳的功效。用于治疗痹痛拘挛、胸胁胀痛、乳汁不通，乳痈肿痛。
丹参具有活血祛瘀，通经止痛，清心除烦，凉血消痈之功效。用于胸痹心痛，脘腹胁痛，瘕瘕积聚，热痹疼痛，心烦不眠，月经不调，痛经经闭，疮疡肿痛。
梳篦叶具有清热利湿，凉血解毒之功效。用于湿热黄疸，蛇咬伤，外伤出血，痛经。
五味子敛肺，滋肾，生津，收汗，涩精。治肺虚喘咳，口干作渴，自汗，盗汗，劳伤羸瘦，梦遗滑精，久泻久痢。
铃子香具有散风寒，通经络，消积之功效。主治风寒感冒，咳嗽，筋骨酸痛，食积腹胀。
黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿，增强心肌收缩力，调节血糖含量。黄芪不仅能扩张冠状动脉，改善心肌供血，提高免疫功能，而且能够延缓细胞衰老的进程。
莪术主治“气血凝滞，心腹胀痛，症瘕，积聚，宿食不消，妇女血瘀经闭，跌打损伤作痛。”块根称“绿丝郁金”，有行气解郁，破瘀，止痛的功用。
棉花根具有止咳平喘，通经止痛之功效。用于咳嗽，气喘，月经不调，崩漏。
炙甘草具有抗炎及抗变态反应作用，可调节机体免疫功能，抗肿瘤和止痛作用。因此炙甘草的主要功效是和中缓急，润肺，解毒，调和诸药。常用于脾胃虚弱，倦怠乏力，心动悸，脉结代，可解附子毒。
王不留行具有活血通经，下乳消肿，利尿通淋的功效。用于经闭，痛经，乳汁不下，乳痈肿痛，淋证涩痛。
制附子回阳救逆，补火助阳，逐风寒湿邪。用于亡阳虚脱，肢冷脉微，阳痿，宫冷，心腹冷痛，虚寒吐泻，阴寒水肿，阳虚外感，寒湿痹痛。
刺蒺藜散风，明目，下气，行血。治头痛，身痒，目赤肿翳，胸满，咳逆，症瘕，乳难，痈疽，瘰疬。平肝；解郁；祛风明目。主头痛；眩晕；胸胁胀痛；乳房胀痛；乳闭不通；经闭；目赤翳障；风疹瘙痒；白癜风；疮疽；瘰疬。
茯苓利水渗湿，健脾，宁心。用于水肿尿少，痰饮眩悸，脾虚食少，便溏泄泻，心神不安，惊悸失眠。
石苇具备利水通淋，清肺泄热等功效。可用于淋痛，尿血，尿路结石，肾炎，崩漏，痢疾，肺热咳嗽，慢性气管炎，金疮，痈疽等。
与现有技术相比，本发明的有益效果是：
本发明制得的药物组合物对良性前列腺增生具有药性平和、标本兼治、疗程短、疗效好、治愈率高、不易复发、无明显不良反应、费用低的特点。能充分发挥中西医之长，在增强各自疗效的同时，减轻各自副作用。本发明制造简单，携带及服用方便，易于实施，实用性强，治愈率高，无明显毒副作用，可以快速改善尿流，减轻病人痛苦，提高生活质量，适用于大多数患群。
具体实施方式
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草5份、银杏20份、丝瓜络1份、丹参3份、梳篦叶30份、五味子1份、铃子香30份、黄芪3份、莪术3份、棉花根5份、炙甘草2份、王不留行2份、制附子1份、刺蒺藜1份、茯苓2份、石苇1份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量5倍重量的水，在30℃浸泡6h后取浸液；在剩余的药渣中加入总药物重量3倍重量的水，在30℃浸泡3h后，取浸液；合并两次所得浸液，60℃加热蒸发，浓缩为60℃环境下相对密度为1.05的稠膏。
（2）将稠膏在-5℃时速冻成粉，过100目筛即得药物组合物。
实施例2
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草30份、银杏50份、丝瓜络18份、丹参25份、梳篦叶70份、五味子20份、铃子香60份、黄芪25份、莪术30份、棉花根30份、炙甘草30份、王不留行25份、制附子20份、刺蒺藜18份、茯苓25份、石苇12份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量10倍重量的水，在60℃浸泡12h后取浸液；在剩余的药渣中加入总药物重量6倍重量的水，在60℃浸泡8h后，取浸液；合并两次所得浸液，70℃加热蒸发，浓缩为60℃环境下相对密度为1.20的稠膏。
（2）将稠膏在0℃时速冻成粉，过200目筛即得药物组合物。
实施例3
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草6份、银杏25份、丝瓜络2份、丹参4份、梳篦叶35份、五味子2份、铃子香35份、黄芪5份、莪术4份、棉花根8份、炙甘草3份、王不留行4份、制附子2份、刺蒺藜2份、茯苓3份、石苇1份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量6倍重量的水，在40℃浸泡8h后取浸液；在剩余的药渣中加入总药物重量4倍重量的水，在40℃浸泡4h后，取浸液；合并两次所得浸液，62℃加热蒸发，浓缩为60℃环境下相对密度为1.10的稠膏。
（2）将稠膏在-4℃时速冻成粉，过120目筛即得药物组合物。
实施例4
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草28份、银杏45份、丝瓜络15份、丹参22份、梳篦叶65份、五味子18份、铃子香55份、黄芪22份、莪术28份、棉花根25份、炙甘草25份、王不留行20份、制附子18份、刺蒺藜15份、茯苓22份、石苇10份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量7倍重量的水，在50℃浸泡9h后取浸液；在剩余的药渣中加入总药物重量5倍重量的水，在50℃浸泡5h后，取浸液；合并两次所得浸液，68℃加热蒸发，浓缩为60℃环境下相对密度为1.15的稠膏。
（2）将稠膏在-3℃时速冻成粉，过160目筛即得药物组合物。
实施例5
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草8份、银杏30份、丝瓜络4份、丹参5份、梳篦叶40份、五味子3份、铃子香38份、黄芪8份、莪术5份、棉花根10份、炙甘草3份、王不留行6份、制附子3份、刺蒺藜3份、茯苓5份、石苇1份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量8倍重量的水，在45℃浸泡8h后取浸液；在剩余的药渣中加入总药物重量4倍重量的水，在45℃浸泡4.5h后，取浸液；合并两次所得浸液，65℃加热蒸发，浓缩为60℃环境下相对密度为1.15的稠膏。
（2）将稠膏在-2℃时速冻成粉，过180目筛即得药物组合物。
实施例6
本发明实施例中，一种治疗良性前列腺增生的药物组合物，按照重量份的原料包括：白花蛇草25份、银杏42份、丝瓜络12份、丹参20份、梳篦叶60份、五味子15份、铃子香52份、黄芪20份、莪术25份、棉花根22份、炙甘草20份、王不留行15份、制附子15份、刺蒺藜12份、茯苓20份、石苇8份。
所述药物组合物的制备方法，包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量8倍重量的水，在45℃浸泡7h后取浸液；在剩余的药渣中加入总药物重量4倍重量的水，在45℃浸泡4h后，取浸液；合并两次所得浸液，65℃加热蒸发，浓缩为60℃环境下相对密度为1.15的稠膏。
（2）将稠膏在-5℃时速冻成粉，过180目筛即得药物组合物。
对良性前列腺增生患者口服本发明实施例5-6的药物组合物，每次1g，每日3次。连续服用4周后，治愈52%，总有效率93.5%。
典型病例
1.张某，男，58岁，精神萎靡，腰部冷痛，四肢不温，双足尤甚，尿液深黄，舌淡嫩，体大有齿痕，苔湿滑，脉沉细无力。超声示:膀胱充盈，前列腺4.7×3.5×3cm3，回声均匀。诊断:前列腺增生症。治以本发明实施例5药物组合物， 口服药物组合物，每次1g，每日3次。服药五天后尿液呈淡黄色。又服药七天后，患者能自行排尿，但不甚畅，继服一周，小便通利，服药四周，夜尿1-2次，四肢转温。超声示:无残余尿液，前列腺4.1×3×2.5cm3。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (8)
1.一种治疗良性前列腺增生的药物组合物，其特征在于，按照重量份的原料包括：白花蛇草5-30份、银杏20-50份、丝瓜络1-18份、丹参3-25份、梳篦叶30-70份、五味子1-20份、铃子香30-60份、黄芪3-25份、莪术3-30份、棉花根5-30份、炙甘草2-30份、王不留行2-25份、制附子1-20份、刺蒺藜1-18份、茯苓2-25份、石苇1-12份。
2.根据权利要求1所述的治疗良性前列腺增生的药物组合物，其特征在于，按照重量份的原料包括：白花蛇草6-28份、银杏25-45份、丝瓜络2-15份、丹参4-22份、梳篦叶35-65份、五味子2-18份、铃子香35-55份、黄芪5-22份、莪术4-28份、棉花根8-25份、炙甘草3-25份、王不留行4-20份、制附子2-18份、刺蒺藜2-15份、茯苓3-22份、石苇1-10份。
3.根据权利要求1所述的治疗良性前列腺增生的药物组合物，其特征在于，按照重量份的原料包括：白花蛇草8-25份、银杏30-42份、丝瓜络4-12份、丹参5-20份、梳篦叶40-60份、五味子3-15份、铃子香38-52份、黄芪8-20份、莪术5-25份、棉花根10-22份、炙甘草3-20份、王不留行6-15份、制附子3-15份、刺蒺藜3-12份、茯苓5-20份、石苇1-8份。
4.根据如权利要求1-3任一所述的治疗良性前列腺增生的药物组合物，其特征在于，其制备工艺包括以下步骤：
（1）取白花蛇草、银杏、丝瓜络、丹参、梳篦叶、五味子、铃子香、黄芪、莪术、棉花根、炙甘草、王不留行、制附子、刺蒺藜、茯苓、石苇放入容器中，加入总药物重量5-10倍重量的水浸泡6-12h后取浸液；在剩余的药渣中加入总药物重量3-6倍重量的水浸泡3-8h后，取浸液；合并两次所得浸液，加热蒸发，浓缩为稠膏；
（2）将稠膏速冻成粉，过100-200目筛即得药物组合物。
5.根据权利要求4所述的治疗良性前列腺增生的药物组合物，其特征在于，步骤（1）中，浓缩为60℃环境下相对密度为1.05-1.20的稠膏。
6.根据权利要求4所述的治疗良性前列腺增生的药物组合物，其特征在于，步骤（1）中，浸泡的温度为30-60℃。
7.根据权利要求4所述的治疗良性前列腺增生的药物组合物，其特征在于，步骤（1）中，加热蒸发的温度为60-70℃。
8.根据权利要求4所述的治疗良性前列腺增生的药物组合物，其特征在于，步骤（2）中，速冻成粉的温度为-5~0℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710436947.0A CN107050396A (zh) | 2017-06-12 | 2017-06-12 | 一种治疗良性前列腺增生的药物组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710436947.0A CN107050396A (zh) | 2017-06-12 | 2017-06-12 | 一种治疗良性前列腺增生的药物组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107050396A true CN107050396A (zh) | 2017-08-18 |
Family
ID=59595249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710436947.0A Pending CN107050396A (zh) | 2017-06-12 | 2017-06-12 | 一种治疗良性前列腺增生的药物组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107050396A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813763A (zh) * | 2012-07-28 | 2012-12-12 | 高加齐 | 瘀浊内阻型良性前列腺增生用的中药 |
| CN103223130A (zh) * | 2013-05-06 | 2013-07-31 | 孙丰卿 | 一种用于治疗前列腺增生肥大的中药组合物及其制剂的制备方法 |
| CN105031505A (zh) * | 2015-03-27 | 2015-11-11 | 张冠军 | 一种治疗良性前列腺增生肥大的药物及其制备方法 |
| CN105497119A (zh) * | 2016-01-25 | 2016-04-20 | 济南星懿医药技术有限公司 | 治疗良性前列腺增生的药物组合物 |
-
2017
- 2017-06-12 CN CN201710436947.0A patent/CN107050396A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813763A (zh) * | 2012-07-28 | 2012-12-12 | 高加齐 | 瘀浊内阻型良性前列腺增生用的中药 |
| CN103223130A (zh) * | 2013-05-06 | 2013-07-31 | 孙丰卿 | 一种用于治疗前列腺增生肥大的中药组合物及其制剂的制备方法 |
| CN105031505A (zh) * | 2015-03-27 | 2015-11-11 | 张冠军 | 一种治疗良性前列腺增生肥大的药物及其制备方法 |
| CN105497119A (zh) * | 2016-01-25 | 2016-04-20 | 济南星懿医药技术有限公司 | 治疗良性前列腺增生的药物组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102973822B (zh) | 一种治疗口臭的药物及其制备方法 | |
| CN102526597B (zh) | 一种治疗口臭的药物及其制备方法 | |
| CN104173988A (zh) | 一种治疗伤风的药物及其制备方法 | |
| CN102697348A (zh) | 药枕及其制作方法 | |
| CN102988649B (zh) | 一种治疗慢性支气管炎的药物及其制备方法 | |
| CN103550694A (zh) | 一种治疗脱发的药物及其制备方法 | |
| CN107334857A (zh) | 一种治疗牛皮癣的内服药 | |
| CN107050396A (zh) | 一种治疗良性前列腺增生的药物组合物 | |
| CN103638495B (zh) | 一种治疗副鼻窦炎的药物及其制备方法 | |
| CN103638464B (zh) | 一种治疗慢性肝炎的药物及其制备方法 | |
| CN103191384B (zh) | 一种治疗足跟痛的药物及其制备方法 | |
| CN102671180B (zh) | 一种治疗风湿腰痛的药物及其制备方法 | |
| CN104248714B (zh) | 治疗宫颈炎的瑶药软胶囊及其制备方法 | |
| CN104107373A (zh) | 治疗脚气、脚臭、脚汗的中药 | |
| CN108653600A (zh) | 一种治疗眼病的药物组方及其制作和使用方法 | |
| CN107375740A (zh) | 一种治疗风湿性关节炎的中药组合物 | |
| CN108524888A (zh) | 一种治疗失眠的药物及其制备方法 | |
| CN107998367A (zh) | 一种消肿散结祛瘀止痛膏药 | |
| CN105194615A (zh) | 一种治疗甲状腺肿大的中药 | |
| CN106421482A (zh) | 一种治疗风热感冒的中药制剂及制备方法 | |
| CN202908369U (zh) | 药枕 | |
| CN104840619A (zh) | 一种治疗肛窦炎的中药组合物 | |
| CN104547831A (zh) | 甲状腺机能亢进患者益气养阴药酒及制备方法 | |
| CN102846900B (zh) | 一种治疗肩关节周围炎的药物及其制备方法 | |
| CN104056217A (zh) | 治疗老年咳喘的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170818 |